Linkage Disequilibrium Mapping of the Replicated Type 2 Diabetes Linkage Signal on Chromosome 1q

Linkage Disequilibrium Mapping of the Replicated Type 2 Diabetes Linkage Signal on Chromosome 1q Inga Prokopenko 1 , 2 , Eleftheria Zeggini 1 , 3 , Robert L. Hanson 4 , Braxton D. Mitchell 5 , N. William Rayner 1 , 2 , Pelin Akan 3 , Leslie Baier 4 , Swapan K. Das 6 , 7 , Katherine S. Elliott 1 , Ma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2009-07, Vol.58 (7), p.1704-1709
Hauptverfasser: PROKOPENKO, Inga, ZEGGINI, Eleftheria, FRAYLING, Timothy M, GROVES, Christopher J, GWILLIAM, Rhian, SCOTT, Laura J, VOIGHT, Benjamin F, HATTERSLEY, Andrew T, CHENG HU, MORRIS, Andrew D, NG, Maggie, PALMER, Colin N. A, HANSON, Robert L, TELLO-RUIZ, Marcela, VAXILLAIRE, Martine, WANG, Cong-Rong, STEIN, Lincoln, CHAN, Juliana, WEIPING JIA, FROGUEL, Philippe, ELBEIN, Steven C, DELOUKAS, Panos, BOGARDUS, Clifton, MITCHELL, Braxton D, SHULDINER, Alan R, MCCARTHY, Mark I, RAYNER, N. William, AKAN, Pelin, BAIER, Leslie, DAS, Swapan K, ELLIOTT, Katherine S, MAO FU
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linkage Disequilibrium Mapping of the Replicated Type 2 Diabetes Linkage Signal on Chromosome 1q Inga Prokopenko 1 , 2 , Eleftheria Zeggini 1 , 3 , Robert L. Hanson 4 , Braxton D. Mitchell 5 , N. William Rayner 1 , 2 , Pelin Akan 3 , Leslie Baier 4 , Swapan K. Das 6 , 7 , Katherine S. Elliott 1 , Mao Fu 5 , Timothy M. Frayling 8 , Christopher J. Groves 1 , 2 , Rhian Gwilliam 3 , Laura J. Scott 9 , Benjamin F. Voight 10 11 12 13 , Andrew T. Hattersley 8 , Cheng Hu 14 , Andrew D. Morris 15 , Maggie Ng 16 , Colin N.A. Palmer 17 , Marcela Tello-Ruiz 18 , Martine Vaxillaire 19 , Cong-rong Wang 14 , Lincoln Stein 18 20 , Juliana Chan 16 , Weiping Jia 14 , Philippe Froguel 19 21 , Steven C. Elbein 6 , Panos Deloukas 3 , Clifton Bogardus 4 , Alan R. Shuldiner 5 , Mark I. McCarthy 1 , 2 , 22 and for the International Type 2 Diabetes 1q Consortium 1 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K; 2 Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.; 3 Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, U.K.; 4 Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona; 5 School of Medicine, University of Maryland, Baltimore, Maryland; 6 Endocrinology Section, Medical Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas; 7 Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas; 8 Institute of Clinical and Biomedical Science, Peninsula Medical School, Exeter, U.K.; 9 Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan; 10 Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts; 11 Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts; 12 Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; 13 Department of Medicine, Harvard Medical School, Boston, Massachusetts; 14 Shanghai Diabetes Institute, Department of Endocrinology & Metabolism, Shanghai Jiaotong University No. 6 People's Hospital, Shanghai, China; 15 Diabetes Research Group, Biomedical Research Institute, University of Dundee, Dundee, U.K.; 16 Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin,
ISSN:0012-1797
1939-327X
DOI:10.2337/db09-0081